GlassScriptPhysician profile
Jason L Garrow
NPI 1720030471
$5,316.92
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.28 · 2023: $4,654 · 2024: $279 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,176 · Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,176.35 |
| Food and Beverage | $1,063.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $4,305.71 | 2023 | 3m Cavilon, Prevena, V.A.C. Dermatac |
| Mentor Worldwide LLC | $262.14 | 2023-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $226.52 | 2022-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Smith+Nephew, INC. | $149.21 | 2022-2025 | Pico 14, Stravix, Stravix Pl |
| Urgo Medical North America, LLC | $119.51 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Sun Pharmaceutical Industries INC. | $76.41 | 2024-2025 | |
| Mindray Ds USA, INC. | $39.07 | 2023 | Te7 Max, Te X |
| Pacira Pharmaceuticals Incorporated | $36.12 | 2023 | Exparel |
| Sientra, INC. | $31.41 | 2022 | |
| Abbvie INC. | $30.74 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $21.36 | 2025 | |
| Motiva USA, LLC | $18.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Garrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.